Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04803006
What this trial is testing

TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)

Who this might be right for
Kidney Transplantation
ITB-Med LLC 4
Testing effectiveness (Phase 2)Study completedNCT00006233
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00469729
What this trial is testing

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid Leukemia+4 more
Gamida Cell -Teva Joint Venture Ltd. 101
Not applicableUnknownNCT01828619
What this trial is testing

Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Peking University People's Hospital 60
Early research (Phase 1)Study completedNCT04082286
What this trial is testing

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Who this might be right for
Acute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaJuvenile Myelomonocytic Leukemia
Great Ormond Street Hospital for Children NHS Foundation Trust 9
Not applicableStudy completedNCT01081405
What this trial is testing

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
HEMATOLOGIC MALIGNANCIES
Fondazione EMN Italy Onlus 20
Large-scale testing (Phase 3)Study completedNCT00928018
What this trial is testing

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

Who this might be right for
Non-hodgkin LymphomaHodgkin Lymphoma
Dana-Farber Cancer Institute 139
Testing effectiveness (Phase 2)Looking for participantsNCT04491370
What this trial is testing

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Who this might be right for
B-cell LymphomaBurkitt LymphomaDiffuse Large B Cell Lymphoma+6 more
New York Medical College 20
Testing effectiveness (Phase 2)Ended earlyNCT00489281
What this trial is testing

Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders

Who this might be right for
Sickle Cell Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 43
Testing effectiveness (Phase 2)Study completedNCT00772811
What this trial is testing

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomaMultiple Myeloma
Cooperative Study Group A for Hematology 38
Testing effectiveness (Phase 2)WithdrawnNCT03417765
What this trial is testing

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Who this might be right for
Lymphoma, Non-Hodgkin's, AdultLymphoma, Hodgkin's, Adult
GlyPharma Therapeutics
Testing effectiveness (Phase 2)UnknownNCT01849939
What this trial is testing

Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaLymphocytic Lymphoma
University Hospital, Clermont-Ferrand 43
Testing effectiveness (Phase 2)Study completedNCT00556452
What this trial is testing

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Who this might be right for
LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+2 more
University of Michigan Rogel Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00599547
What this trial is testing

Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients

Who this might be right for
Myelofibrosis
Universitätsklinikum Hamburg-Eppendorf 106
Testing effectiveness (Phase 2)Study completedNCT00782379
What this trial is testing

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Northside Hospital, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT01220297
What this trial is testing

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Who this might be right for
Hematologic DiseasesAcute-graft-versus-host DiseaseLeukemia+2 more
Stanford University 3
Testing effectiveness (Phase 2)Looking for participantsNCT06928662
What this trial is testing

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Who this might be right for
Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia+11 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT06481592
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Who this might be right for
Endometrial Cancer
Iovance Biotherapeutics, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT03367546
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Who this might be right for
Sickle Cell DiseaseThalassemiaHigh Risk Hematologic Disorders+2 more
Masonic Cancer Center, University of Minnesota 5
Large-scale testing (Phase 3)Ended earlyNCT01203228
What this trial is testing

Dose-reduced Versus Standard Conditioning in MDS/sAML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid Leukemia
European Society for Blood and Marrow Transplantation 129
Next Page